{"id":17270,"date":"2021-06-02T14:30:39","date_gmt":"2021-06-02T12:30:39","guid":{"rendered":"https:\/\/www.izb-online.de\/leukocare-ernennt-dr-georg-doenges-zum-chief-financial-officer\/"},"modified":"2021-06-02T14:35:32","modified_gmt":"2021-06-02T12:35:32","slug":"leukocare-ernennt-dr-georg-doenges-zum-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/leukocare-appoints-dr-georg-doenges-as-chief-financial-officer\/","title":{"rendered":"Leukocare appoints Dr. Georg D\u00f6nges as Chief Financial Officer"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

Leukocare appoints Dr. Georg D\u00f6nges as Chief Financial Officer<\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine-lead”]Dr. Georg D\u00f6nges has already been with Leukocare since January 2018 and has headed the company’s finance department as Vice President Finance for the last three years.[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]June 2021[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_single_image image=”17266″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 Leukocare[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Dr. Georg D\u00f6nges, CFO at Leukocare[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote” css=”.vc_custom_1611310713611{margin-top: 33px !important;}”][vc_column_inner][vc_column_text]<\/p>\n

\u201cOver the last few years, I\u2019ve been closely involved in the company\u2019s growth and took part in the ongoing development of its corporate strategy. I am proud to take up the role as CFO of this exciting company and to support Leukocare in further enhancing its unique technology as well as expanding its business.\u201d<\/h6>\n

Dr. Georg D\u00f6nges
\nCFO at Leukocare<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy” css=”.vc_custom_1591795890737{margin-top: 21px !important;}”][vc_column_inner][vc_column_text]Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, has appointed Dr. Georg D\u00f6nges as Chief Financial Officer. Georg has led the company\u00b4s financial department as Vice President Finance for the last three years. Before joining Leukocare, Georg had spent more than ten years in leading positions in biotech and other industries. Being a molecular biologist by training, he has achieved an impressive career path in various roles and functions in financial departments of public companies, e.g. as Head of Investor Relations at MediGene AG, Martinsried, Germany, and as Manager Finance Transformation coordinating the re-organization of corporate finance at GfK SE, Nuremberg, Germany, a KKR portfolio company. Georg earned a PhD at the Max-Planck-Institute of Biochemistry, Martinsried, Germany, and is a Certified International Investment Analyst (CIIA).<\/p>\n

Georg joined Leukocare in January 2018 and built the company\u2019s finance department including the insourcing of accounting and controlling functions. He oversaw two financing rounds as well as the founding of the company\u2019s US-subsidiary Leukocare Inc., for which he acts as CFO and co-managing director.<\/p>\n

Michael Scholl, Chief Executive Officer, said, \u201cI am very pleased to announce Georg\u00b4s appointment as Leukocare\u00b4s new CFO. We have been working together for a number of years and successfully closed several deals that laid the foundation for the company\u00b4s growth. Leukocare\u2019s ambitious future corporate goals require strategic and solid financial management and I am convinced that Georg is the perfect choice for this role. He brings a deep understanding and many years of relevant experience from both aspects \u2013 biotech and finance \u2013 to the table. I\u00b4m very much looking forward to further collaborating with him.\u201d<\/p>\n

Dr. Georg D\u00f6nges, Chief Financial Officer, commented, \u201cOver the last few years, I\u2019ve been closely involved in the company\u2019s growth and took part in the ongoing development of its corporate strategy. I am proud to take up the role as CFO of this exciting company and to support Leukocare in further enhancing its unique technology as well as expanding its business.\u201d[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n

\n \n